Editorials What have we learnt from the rosiglitazone saga? BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d1354 (Published 17 March 2011) Cite this as: BMJ 2011;342:d1354 Article Related content Metrics Responses Peer review Related articles Research Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies Published: 17 March 2011; BMJ 342 doi:10.1136/bmj.d1309 Letter Should we throw the baby out with the bathwater? Published: 21 April 2011; BMJ 342 doi:10.1136/bmj.d2566 Editorial Patient information on prescribed drugs Published: 03 May 2011; BMJ 342 doi:10.1136/bmj.d1924 Research Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis Published: 12 March 2012; BMJ 344 doi:10.1136/bmj.e1369 See more Cardiovascular disease: Just one in 12 eligible people had health check last year, watchdog finds BMJ November 13, 2024, 387 q2518; DOI: https://doi.org/10.1136/bmj.q2518 Semaglutide’s CVD indication could cost US Medicare $145bn extra a year BMJ August 28, 2024, 386 q1878; DOI: https://doi.org/10.1136/bmj.q1878 Semaglutide: UK regulator approves drug for prevention of cardiovascular events BMJ July 25, 2024, 386 q1660; DOI: https://doi.org/10.1136/bmj.q1660 Why India is failing to track heatstroke fatalities properly BMJ July 17, 2024, 386 q1437; DOI: https://doi.org/10.1136/bmj.q1437 Mail on Sunday articles that accused three commentators of being “statin deniers” were misinformed, judge rules BMJ June 26, 2024, 385 q1424; DOI: https://doi.org/10.1136/bmj.q1424 Cited by... Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysisAbstract Fulltext PDF State Medicaid Programs Did Not Make Use Of Prior Authorization To Promote Safer Prescribing After Rosiglitazone WarningAbstract Fulltext PDF Patient information on prescribed drugsAbstract Fulltext PDF Should we throw the baby out with the bathwater?Abstract Fulltext PDF Authors' replyAbstract Fulltext PDF Rosiglitazone vs. Pioglitazone -- What Are the Odds?Abstract Fulltext PDF
